Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03078062Completed
Randomised, double-blind trial of dexamethasone, sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Regression of sensory block by 2 dermatomes at 2 hours. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03078062.